{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:22:55Z","timestamp":1789928575544,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.ymgme.2010.06.008","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T08:31:15Z","timestamp":1277281875000},"page":"208-213","source":"Crossref","is-referenced-by-count":20,"title":["Trans-generational exposure to low levels of rhodamine B does not adversely affect litter size or liver function in murine mucopolysaccharidosis type IIIA"],"prefix":"10.1016","volume":"101","author":[{"given":"Ainslie L.K.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.06.008_bb0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2010.06.008_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/bj3290145","article-title":"Recombinant human sulphamidase: expression, amplification, purification and characterization","volume":"329","author":"Bielicki","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","article-title":"Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice","volume":"90","author":"Hemsley","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0030","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2010.06.008_bb0035","first-page":"273","article-title":"Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation","volume":"10","author":"Resnick","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0040","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1005526628598","article-title":"Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling","volume":"22","author":"Sivakumur","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0045","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2007.06.016","article-title":"Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA","volume":"92","author":"Roberts","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/01.pdr.0000233037.00707.da","article-title":"Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA","volume":"60","author":"Roberts","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0041-008X(61)90012-6","article-title":"Studies of the metabolism of rhodamine B","volume":"3","author":"Webb","year":"1961","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0041-008X(61)90033-3","article-title":"Biochemical and toxicologic studies of rhodamine B and 3,6-diaminofluroan","volume":"3","author":"Webb","year":"1961","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.1956.79","article-title":"The induction of tumours of the subcutaneous tissues, liver and intestine in the mouse by certain dye-stuffs and their intermediates","volume":"10","author":"Bonser","year":"1956","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymgme.2010.06.008_bb0075","first-page":"29A","article-title":"Subacute oral toxicity of nine D&C coal tar colors","volume":"122","author":"Hansen","year":"1959","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0080","first-page":"125","article-title":"The toxic effect of rhodamine B in rats","volume":"24","author":"Nainggolan-Sihombing","year":"1984","journal-title":"Paediatr. Indones."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/15563658708992660","article-title":"Acute exposure to rhodamine B","volume":"25","author":"Dire","year":"1987","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0090","first-page":"523","article-title":"Rhodamine B ingestion as a cause of fluorescent red urine","volume":"143","author":"Kelner","year":"1985","journal-title":"West. J. Med."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0095","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2010.06.008_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.21682","article-title":"Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA","author":"Roberts","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0003-2697(73)90377-1","article-title":"New method for quantitative determination of uronic acids","volume":"54","author":"Blumenkrantz","year":"1973","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diaclin.23.3.115","article-title":"Elevated liver function tests in type 2 diabetes","volume":"23","author":"Harris","year":"2005","journal-title":"Clin. Diab."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1098\/rstb.2003.1272","article-title":"Gaucher disease and the clinical experience with substrate reduction therapy","volume":"358","author":"Zimran","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ejhg.5201623","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses","author":"Piotrowska","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0125","unstructured":"A. Friso, R. Tomanin, M. Salvalaio, M. Scarpa, Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2009.06.013","article-title":"Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice","volume":"98","author":"Malinowska","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0135","doi-asserted-by":"crossref","unstructured":"G. Wegrzyn, J. Jakobkiewicz-Banecka, M. Gabig-Ciminska, E. Piotrowska, M. Narajczyk, A. Kloska, M. Malinowska, D. Dziedzic, I. Golebiewska, M. Moskot, A. Wegrzyn, Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem. Soc. Trans. 38 695-701.","DOI":"10.1042\/BST0380695"},{"key":"10.1016\/j.ymgme.2010.06.008_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","article-title":"Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients","volume":"69","author":"Piotrowska","year":"2008","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ymgme.2010.06.008_bb0145","first-page":"51","article-title":"Experimental study of xanthene dyes as carcinogenic agents","volume":"47","author":"Umeda","year":"1956","journal-title":"Gan"},{"key":"10.1016\/j.ymgme.2010.06.008_bb0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl J. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210002283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210002283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T06:50:38Z","timestamp":1544424638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210002283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1096719210002283"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.06.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}